🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will investigate the safety and efficacy of efimosfermin alfa in...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2026-07-22
Trial ID
NCT07701993
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, prelimin...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2025-04-09
Trial ID
NCT06920043
Treatments Being Tested
This study will evaluate the safety and tolerability of Efimosfermin Alfa f...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2025-12-12
Trial ID
NCT07221188
Treatments Being Tested
This is a first time in Asia (FTIA) study designed to evaluate the safety, ...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2026-03-05
Trial ID
NCT07335198
Treatments Being Tested
This is a multi-center, randomized, two-part (Part A and Part B) study inve...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2026-07-22
Trial ID
NCT07704892
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of efimosfer...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2025-10-24
Trial ID
NCT07221227
Treatments Being Tested
This study is designed to study the pharmacokinetic (PK) and safety profile...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2026-03-13
Trial ID
NCT07358546
Treatments Being Tested
This is a dose-ranging study to evaluate safety of efimosfermin alfa and to...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-23
Trial ID
NCT07791043
Treatments Being Tested